Trials / Completed
CompletedNCT03757533
Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease
Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease: A Prospective Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Inflammatory bowel disease (IBD) including Crohn's disease (CD) and Ulcerative colitis (UC) is a chronic idiopathic intestinal disorder involving the interplay of environmental, immunomodulatory and genetic causative factors. Treatment for IBD is multimodal and includes lifestyle modification, chronic pharmacotherapy and surgery. Given the need for chronic pharmacotherapy, medication adherence is a crucial therapeutic goal in the management of IBD. In fact, medication non-adherence has been associated with greater risk of relapse and increased healthcare costs. In a previous study, the investigators found clinically identifiable risk factors for non-adherence for self-injectable biologic medications in a population with moderate to severe CD. These risk factors included smoking, prior biologic use, psychiatric history, and current narcotic use. The primary objective of this study is to use a multidisciplinary team approach that implements a targeted coaching intervention to promote behavioral change and improve medication adherence in adult patients with IBD who are at high risk of non-adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Health Coaching | 10 phone calls with a trained health coach |
| OTHER | Surveys | Surveys to assess Behavioural and Psychosocial measures |
Timeline
- Start date
- 2019-06-11
- Primary completion
- 2023-07-21
- Completion
- 2023-07-21
- First posted
- 2018-11-29
- Last updated
- 2023-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03757533. Inclusion in this directory is not an endorsement.